The primary goal of lung cancer screening is early detection and timely treatment. Early-stage lung cancers are typically smaller and less likely to have spread beyond the lung, leading to better outcomes. In Minnesota, the five-year survival rate for lung cancers diagnosed at the site in the body where they started (local stage) is 68% compared to just 21% for cancers that have spread to distant sites in the body (distant stage).
While early diagnosis and treatment are important, other factors contribute to health disparities and inequities in lung cancer outcomes. Social determinants of health such as access to transportation, health insurance coverage, and the cost of health care can create significant barriers to lung cancer screening and treatment for certain populations.
Addressing these social determinants of health is essential for developing lung cancer screening programs, interventions, and policies that target populations most in need of improved outcomes. This interactive dashboard presents Minnesota screening data that showcases how selected social determinants of health impact both measures of lung cancer burden (incidence and mortality) and lung cancer screening rates. This tool is designed to support program planning, decision making, and resource allocation. The resource section at the end of this page includes links to additional data sources, as well as background information on social determinants of health.
How to use these data
This dashboard allows you to view different data indicators. Visit MCRS: Cancer Technical Notes to learn more about data definitions and how to interpret the data. Specific instructions on how to interpret each chart are included below.
Back to top